Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health, Inc.    CAH

CARDINAL HEALTH, INC.

(CAH)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 02/25 02:21:21 pm
55.74 USD   -4.13%
12:57pOil slips for 3rd day as virus fears outweigh supply cuts
RE
09:31aActivist Bramson criticises Barclays over CEO's Epstein links
RE
08:43aBritain's financial watchdog flags data breach on website
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/18/2020 02/19/2020 02/20/2020 02/21/2020 02/24/2020 Date
59.01(c) 59.35(c) 60.42(c) 59.72(c) 58.14(c) Last
2 276 473 1 896 891 2 688 023 2 275 376 2 105 470 Volume
-1.02% +0.58% +1.80% -1.16% -2.65% Change
More quotes
Financials (USD)
Sales 2020 153 B
EBIT 2020 2 322 M
Net income 2020 -4 239 M
Debt 2020 4 400 M
Yield 2020 3,42%
Sales 2021 160 B
EBIT 2021 2 308 M
Net income 2021 1 242 M
Debt 2021 3 850 M
Yield 2021 3,54%
P/E ratio 2020 -4,03x
P/E ratio 2021 13,7x
EV / Sales2020 0,14x
EV / Sales2021 0,13x
Capitalization 16 964 M
More Financials
Company
Cardinal Health is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (88.6%); - distribution of medical, surgical and laboratory products (11.4%).... 
Sector
Drug Retailers
Calendar
03/10 | 07:30amPresentation
More about the company
Surperformance© ratings of Cardinal Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDINAL HEALTH, INC.
12:57pOil slips for 3rd day as virus fears outweigh supply cuts
RE
09:31aActivist Bramson criticises Barclays over CEO's Epstein links
RE
08:43aBritain's financial watchdog flags data breach on website
RE
02/24S.Africa's maize output expected to rise 29% on good rains, higher plantings
RE
02/24Montenegro introduces cap and trade scheme for major CO2 emitters
RE
02/22Tesla resumes tree cutting in Germany to build Gigafactory
RE
02/21RAG foundation wants "significant minority stake" in Thyssen's lift unit-repo..
RE
02/21Report Saudi Arabia to break from OPEC+ alliance is 'nonsense' - Saudi Energy..
RE
02/21Daimler warns of "significant adverse effects" of virus outbreak
RE
02/20EXCLUSIVE : Westinghouse set to sign pact with Indian firm for nuclear reactors ..
RE
02/20Credit Suisse investment group buys NorthPoint Technology
RE
02/20Lebanon's Bank Audi collects $210 million for capital increase
RE
02/19French judges step up Ghosn probe over palace party, Oman dealings
RE
02/19EXCLUSIVE : 'Made in Russia' passenger jet finds a single buyer, Aeroflot
RE
02/19Massmart CEO says not ready to let Game department chain fail
RE
More news
News in other languages on CARDINAL HEALTH, INC.
02/21Daimler met en garde contre les conséquences du coronavirus
02/18RENAULT : Bercy met en garde Renault contre les suppressions d'emplois
02/14NIBC HOLDING N.V. : Blackstone propose 1,44 Md€ pour un rachat
01/21OLIVIER BRANDICOURT : Adieu Diabetes - Weichenstellung an der Seine
2019CARDINAL HEALTH : Ex-dividend day for
More news
Analyst Recommendations on CARDINAL HEALTH, INC.
More recommendations
Sector news : Drug Retailers - NEC
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
More sector news : Drug Retailers - NEC
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 58,81  $
Last Close Price 58,14  $
Spread / Highest target 17,0%
Spread / Average Target 1,16%
Spread / Lowest Target -17,4%
EPS Revisions
Managers
NameTitle
Michael C. Kaufmann Chief Executive Officer & Director
Gregory B. Kenny Non-Executive chairman
David C. Evans Chief Financial Officer
Brian S. Rice Chief Information Officer & Executive VP
Calvin Ramarro Darden Independent Director
Sector and Competitors